Grand Rapids, MI2 Active Studies

Peripheral Artery Disease Clinical Trials in Grand Rapids, MI

Find 2 actively recruiting peripheral artery disease clinical trials in Grand Rapids, MI. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
410
Enrolling

Recruiting Peripheral Artery Disease Studies in Grand Rapids

About Peripheral Artery Disease Clinical Trials in Grand Rapids

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 2 peripheral artery disease clinical trials recruiting participants in Grand Rapids, MI. These studies are seeking a combined 410 participants. Research is being sponsored by Corewell Health West, Avinger, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Grand Rapids — FAQ

Are there peripheral artery disease clinical trials in Grand Rapids?

Yes, there are 2 peripheral artery disease clinical trials currently recruiting in Grand Rapids, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Grand Rapids?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Rapids research site will contact you about next steps.

Are clinical trials in Grand Rapids free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grand Rapids studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 2 active trials in Grand Rapids are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 17, 2026 from ClinicalTrials.gov